Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)

Market Cap	2.47B -23.6%
Revenue (ttm)	3.16B -23.9%
Net Income	84.86M -25.4%
EPS	0.18 -25.5%
Shares Out	464.69M
PE Ratio	29.08
Forward PE	n/a
Dividend	0.10 (1.88%)
Ex-Dividend Date	Jun 18, 2026

Volume	8,407,440
Open	5.39
Previous Close	5.34
Day's Range	5.28 - 5.41
52-Week Range	4.95 - 7.35
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:000153

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company offers biopharmaceuticals, chemical pharmaceuticals, traditional Chinese medicine preparations, processed Chinese medicinal herbs, and raw materials. It also provides antipyretics and analgesics, gynecological and pediatric drugs, nervous system drugs, cardiovascular system drugs, urinary system drugs, nutritional drugs, and antibiotics. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 4,278
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000153

Financial Performance

In 2025, SHE:000153's revenue was 3.86 billion, a decrease of -9.95% compared to the previous year's 4.28 billion. Earnings were 99.42 million, a decrease of -38.19%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error